ArticleNeuro-oncology advances

A phase Ib study evaluating the c-MET inhibitor INC280 (capmatinib) in combination with bevacizumab in patients with high-grade glioma.

Gerald S Falchook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.